Fingerprint
Dive into the research topics of 'A phase 2 study of ATRA, arsenic trioxide, and gemtuzumab ozogamicin in patients with high-risk APL (SWOG 0535)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Jeffrey E. Lancet, Anna B. Moseley, Steven E. Coutre, Daniel J. DeAngelo, Megan Othus, Martin S. Tallman, Mark R. Litzow, Rami S. Komrokji, Harry P. Erba, Frederick R. Appelbaum
Research output: Contribution to journal › Article › peer-review